President Donald Trump (R-US) signed an executive order Monday directing the Department of Health and Human Services to alter childhood vaccination schedules [2].
The move marks a significant shift in federal guidance on immunization. By calling for a reassessment of how vaccines are sequenced, the order challenges long-standing public health protocols regarding the timing of pediatric shots.
The executive order, signed on Monday, Aug. 10, 2026 [2], calls for the combined measles-mumps-rubella (MMR) vaccine to be split into three separate shots [1]. It further directs that childhood vaccines be spaced out across separate doctor visits to reduce the number of injections administered during a single appointment [3].
Trump said the order is intended to reassess the timing and sequencing of vaccines to address concerns about vaccine safety [3]. The directive focuses on reducing the immediate burden of multiple shots on children during individual clinic visits [3].
However, the order faces immediate practical hurdles. Reports indicate that the individual vaccines required to split the MMR shot are not currently available in the U.S. [1]. Some critics have noted that the order demands the use of split shots that do not exist within the current domestic medical supply chain [1].
While some sources describe the order as adding flexibility to the childhood vaccine schedule, others emphasize the specific demand for the MMR split [1, 4]. The Department of Health and Human Services is now tasked with implementing these changes to the national approach to pediatric immunization [3].
“The executive order calls for the combined measles-mumps-rubella (MMR) vaccine to be split into three separate shots.”
This executive order represents a move toward a decentralized vaccination schedule, prioritizing parental preference and perceived safety over the efficiency of combined doses. If implemented, it would require a complete overhaul of the U.S. vaccine manufacturing and distribution system, as the individual components of the MMR vaccine are not currently produced for the domestic market.
